242 related articles for article (PubMed ID: 36672201)
1. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting
Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
[TBL] [Abstract][Full Text] [Related]
5. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation.
Yadav VK; Huang YJ; George TA; Wei PL; Sumitra MR; Ho CL; Chang TH; Wu ATH; Huang HS
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560222
[TBL] [Abstract][Full Text] [Related]
7. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
8. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
9. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
[TBL] [Abstract][Full Text] [Related]
10. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
[TBL] [Abstract][Full Text] [Related]
11. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
12. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
13. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
14. ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin.
Dai G; Wang D; Ma S; Hong S; Ding K; Tan X; Ju W
Phytomedicine; 2022 Jul; 102():154149. PubMed ID: 35567995
[TBL] [Abstract][Full Text] [Related]
15. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
16. Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages.
Xu H; Zhang Y; Peña MM; Pirisi L; Creek KE
Carcinogenesis; 2017 Mar; 38(3):281-292. PubMed ID: 28199476
[TBL] [Abstract][Full Text] [Related]
17. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
[TBL] [Abstract][Full Text] [Related]
18. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
[TBL] [Abstract][Full Text] [Related]
19. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
[TBL] [Abstract][Full Text] [Related]
20. Sophocarpine Inhibits Tumorgenesis of Colorectal Cancer via Downregulation of MEK/ERK/VEGF Pathway.
Wang Q; Wang T; Zhu L; He N; Duan C; Deng W; Zhang H; Zhang X
Biol Pharm Bull; 2019 Nov; 42(11):1830-1838. PubMed ID: 31434836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
